A
Atossa Therapeutics (ATOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which th... Read more
- USD0.81
- USD0.84
- USD0.81
- USD1.71
- 31.70%
- --
- 507.79k
- 624.25k
- 110M
- 0.55
- -51.70%
Stock News
3 hours ago
Q1 2025 PAR Technology Corp Earnings Call
Yahoo
5 hours ago
Research Frontiers Incorporated (REFR) Q1 2025 Earnings Call Transcript
SeekingAlpha
6 hours ago
Weekly Commentary: Asian-Crisis-In-Reverse Feel
SeekingAlpha
6 hours ago
Guess?, Inc. Is Not Particularly Attractive At Current Prices
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
